Priavoid
PrivateLast Round
Grant
Oct 1, 2024
Total Funding Raised
$8.47M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Priavoid operates in Healthcare & Life Sciences and is based in Dusseldorf. Its latest recorded funding round was a Grant round in October 2024.
Priavoid is a biopharmaceutical company developing a novel class of orally available all-D-peptide therapeutics to inhibit and reverse disease-specific protein aggregation in neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Priavoid Comparables
Compare Priavoid with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acumen Pharmaceuticals | 78% | |
| AC Immune SA | 78% | |
| Alzinova | 77% |
For institutional investors. Book with your work email.
Priavoid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2024 | ||||
| Series A | Feb 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Priavoid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rainwater Charitable Foundation | Grant |
| Alzheimer's Association | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jul 20, 2026
Open roles increased to 4, representing 21% of headcount.
For institutional investors. Book with your work email.
Priavoid Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Priavoid's valuation, stock price, and market status.
Is Priavoid a public or private company?
Priavoid is a private company.
What is the current stock price of Priavoid?
Priavoid is a private company, so its shares have no public market price. Caplight tracks Priavoid's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Priavoid worth (valuation)?
Valuation information for Priavoid is not publicly available.
Can I buy Priavoid stock?
Priavoid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Priavoid's last funding round?
Priavoid's most recent funding round was Grant on October 1, 2024.
Who are the main investors in Priavoid?
Key investors in Priavoid include Rainwater Charitable Foundation, Alzheimer's Association.
Will Priavoid IPO soon?
No public IPO plans have been announced for Priavoid.
How can I track Priavoid secondary market activity?
Caplight tracks bids, offers, and trades in Priavoid's shares on secondary markets.